Tradestie Institutional Equity Comparison Engine

AXNX vs LIVN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

LIVN Overall Edge

LIVN Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to LivaNova PLC Ordinary Shares (LIVN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AXNX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus LIVN at 19.2x Forward P/E and 14.3% operating margin (+9.9% YoY). In options structure, AXNX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against LIVN sits in CONSOLIDATION (11th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner LIVN
AXNX N/M vs LIVN 19.2x Fwd P/E
Growth & Margin Winner LIVN
Op Margin N/A vs 14.3% ยท YoY N/A vs +9.9%
Momentum & Technical Winner LIVN
1Y +16.9% vs +68.3% ยท 52W Pos 50% vs 81%
Options & Structure Winner LIVN
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (11th %ile IV)
AXNX US Equity
AXNX
Institutional Equity
$0.83
-8.28% 1D
Market Cap N/A
1M Return -26.54%
1Y Return +16.92%
Forward P/E N/M
Unified AI Score
52.1 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
LIVN NASDAQ
LivaNova PLC Ordinary Shares
Electromedical & Electrotherapeutic Apparatus
$90.73
-1.46% 1D
Market Cap $5.1B
1M Return +11.64%
1Y Return +68.3%
Forward P/E 19.2x
Unified AI Score
41.9 / 100 SELL
Tech 31.0 Fund 41.0 Flow 72.0 Mom 26.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AXNX +16.92% LIVN +68.3% Spread: +1.88 pp (LIVN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AXNX TTM Op. Margin: N/A LIVN TTM Op. Margin: 14.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AXNX vs LIVN. Trailing 12-month operating profitability (AXNX N/A vs LIVN 14.3%) and valuation multiples (AXNX N/M vs LIVN 19.2x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AXNX (1) vs LIVN (9)
Institutional Metric AXNX LIVN Criterion Row Winner
Market Capitalization Scale N/A $5.1B Larger Scale LIVN
Trailing P/E Ratio Valuation N/M 26.4x Lower Multiple LIVN
Forward P/E Ratio Valuation N/M 19.2x Lower Multiple LIVN
Revenue Growth (YoY) Growth N/A +9.9% Higher Growth LIVN
Operating Margin (TTM) Profitability N/A 14.3% Higher Margin LIVN
Net Profit Margin Profitability N/A 13.0% Higher Margin LIVN
Return on Equity (ROE) Capital Efficiency N/A 15.5% Higher ROE LIVN
52-Week Range Position Momentum 50% ($0โ€“$1) 81% ($53โ€“$99) Stronger Trend LIVN
Beta / 30D Volatility Risk Regime N/A 0.92ฮฒ ยท 66% Vol Lower Realized Risk LIVN
Unified Institutional Score Composite Signal 52.1 / 100 (HOLD) 41.9 / 100 (SELL) Higher Composite AXNX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AXNX vs LIVN Buy Guide
AXNX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AXNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
LIVN CONSOLIDATION
98d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 11th %ile
IV Regime Compressed (<25th %ile)
Live LIVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AXNX nor LIVN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.